Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Interleukin-6
100%
Transforming Growth Factor-β
100%
Metastatic Prostatic Carcinoma
100%
Elevated Levels
100%
Granulocyte Colony-stimulating Factor (G-CSF)
66%
Tumor Necrosis Factor-α
66%
Prostate Cancer
50%
Total Prostate-specific Antigen
50%
Metastasis
33%
Commercially Available
33%
Enzyme-linked Immunosorbent Assay (ELISA)
33%
Prostate-specific Antigen
33%
Serum IL-6
33%
Androgen Ablation
33%
Platelet-poor Plasma
33%
Malignancy
16%
Cell Culture
16%
Prostate
16%
Statistical Analysis
16%
Prostate Cancer Screening
16%
Systemic Circulation
16%
Multivariate Analysis
16%
Digital Rectal Examination
16%
Bone Metastasis
16%
Lymph Node Metastasis
16%
Before Surgery
16%
Tumor Burden
16%
Blood Specimen
16%
Kruskal-Wallis Test
16%
Seminal Vesicle Involvement
16%
Pelvic Lymph Node Dissection
16%
Prostatectomy Specimen
16%
N1 Disease
16%
Extraprostatic Extension
16%
Lymph Node Staging
16%
Medicine and Dentistry
Cancer Growth Factor
100%
Fibrinogen
100%
Interleukin 6
100%
Prostate Carcinoma
100%
Prostate Specific Antigen
83%
Prostate Cancer
66%
Tumor Necrosis Factor
66%
Granulocyte Macrophage Colony Stimulating Factor
66%
Cytokine
50%
Diseases
33%
Metastatic Carcinoma
33%
Androgen
33%
Enzyme Linked Immunosorbent Assay
33%
Thrombocyte Poor Plasma
33%
Malignant Neoplasm
16%
Cancer
16%
Neoplasm
16%
Cell Culture
16%
Cancer Screening
16%
Pelvis
16%
Digital Rectal Examination
16%
Multivariate Analysis
16%
Analysis of Variance
16%
Bone Metastasis
16%
Retroperitoneal Lymph Node Dissection
16%
Lymph Node Metastasis
16%
Prostatectomy
16%
Kruskal Wallis Test
16%
Seminal Vesicle
16%
Systemic Circulation
16%